Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas

被引:49
|
作者
Niijima, M
Yamaguchi, T
Ishihara, T
Hara, T
Kato, K
Kondo, F
Saisho, H
机构
[1] Chiba Univ, Dept Med 1, Sch Med, Chiba, Japan
[2] Chiba Univ, Dept Pathol 2, Sch Med, Chiba, Japan
关键词
intraductal papillary-mucinous tumor of the pancreas; cyclooxygenase-1 (COX-1); cyclooxygenase-2 (COX-2); proliferating cell nuclear antigen; immunohistochemistry; in situ hybridization;
D O I
10.1002/cncr.10358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to investigate COX-2 expression in intraductal papillary-mucinous tumor of the pancreas (IPMT) using immunohistochemical staining (111) and in situ hybridization (ISH). METHODS. Immunohistochemical staining of COX-2 was performed using samples from 42 patients with IPMT (hyperplasia, 10; adenoma, 13; noninvasive adenocarcinoma, 13; invasive adenocarcinoma, 6) and from 10 patients with ductal pancreatic adenocarcinoma, 10 with chronic pancreatitis, and 6 normal pancreatic tissues as controls. Also, COX-2 was determined in five patients with IPMT noninvasive adenocarcinoma, in whom all histologic types, hyperplasia, adenoma, and adenocarcinoma were observed in the same excised specimens. Furthermore, Ill of proliferating cell nuclear antigen (PCNA) was performed, and the labeling index (LI) was calculated to investigate the correlation with COX-2. To confirm COX-2 mRNA, the authors performed ISH in 20 IPMT patients. RESULTS, COX-2 was positive in 0%, 0%, and 10% of pancreatic duct epithelial cells from normal pancreatic tissue, chronic pancreatitis, and IPMT hyperplasia, respectively. Whereas it was positive in 69%, 77%, 67%, and 80% of IPMT adenoma, IPMT noninvasive adenocarcinoma, IPMT invasive adenocarcinoma, and ductal pancreatic adenocarcinoma, respectively, showing significant differences between IPMT hyperplasia and IPMT adenoma or IPMT adenocarcinoma (noninvasive and invasive adeno carcinoma). In the same patient, COX-2 was negative in the hyperplasia region but positive in adenoma and adenocarcinoma regions, showing results reflecting the progression of the disease. In the COX-2 negative group, PCNA-LI was 19.2 +/- 17.9%, and 33.5 +/- 15.7% in the positive group, a significant difference. On ISH COX-2 mRNA was expressed in three of four and seven of eight COX-2 positive patients with IPMT adenoma and adenocarcinoma, respectively CONCLUSIONS. COX-2 was highly expressed in adenoma and adenocarcinoma in IPMT, showing a relation to the histologic grade of IPMT. (C) 2002 American Cancer Society.
引用
收藏
页码:1565 / 1573
页数:9
相关论文
共 50 条
  • [21] Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature
    Loftus, EV
    OlivaresPakzad, BA
    Batts, KP
    Adkins, MC
    Stephens, DH
    Sarr, MG
    Dimagno, EP
    GASTROENTEROLOGY, 1996, 110 (06) : 1909 - 1918
  • [22] Small intraductal papillary-mucinous adenomas of the pancreas
    Ratcliffe, N
    Terhune, PG
    Longnecker, DS
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1996, 120 (12) : 1111 - 1115
  • [23] HASTE MR cholangiopancreatography in the evaluation of intraductal papillary-mucinous tumors of the pancreas
    Fukukura, Y
    Fujiyoshi, F
    Sasaki, M
    Ichinari, N
    Inoue, H
    Kajiya, Y
    Nakajo, M
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1999, 23 (02) : 301 - 305
  • [24] Expression of laminin-5-γ-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas
    Fukushima, N
    Sakamoto, M
    Hirohashi, S
    MODERN PATHOLOGY, 2001, 14 (05) : 404 - 409
  • [25] Pancreatectomy for intraductal papillary-mucinous tumor of the pancreas
    Partensky, C
    Berger, F
    Ponchon, T
    Valette, PJ
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (11): : 938 - 945
  • [26] Mucinous cystic neoplasm of the pancreas or intraductal papillary-mucinous tumour of the pancreas
    Yamaguchi, K
    Yokohata, K
    Noshiro, H
    Chijiiwa, K
    Tanaka, M
    EUROPEAN JOURNAL OF SURGERY, 2000, 166 (02) : 141 - 148
  • [27] Intraductal papillary-mucinous neoplasms of the pancreas - An analysis of in situ and invasive carcinomas in 28 patients
    Adsay, NV
    Conlon, KC
    Zee, SY
    Brennan, MF
    Klimstra, DS
    CANCER, 2002, 94 (01) : 62 - 77
  • [28] Endocrine cells in intraductal papillary-mucinous neoplasms of the pancreas A histochemical and immunohistochemical study
    T. Terada
    Tetsuo Ohta
    Yukisato Kitamura
    Keigo Ashida
    Yoshiko Matsunaga
    Masako Kato
    Virchows Archiv, 1997, 431 : 31 - 36
  • [29] Endocrine cells in intraductal papillary-mucinous neoplasms of the pancreas - A histochemical and immunohistochemical study
    Terada, T
    Ohta, T
    Kitamura, Y
    Ashida, K
    Matsunaga, Y
    Kato, M
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1997, 431 (01): : 31 - 36
  • [30] Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: Clinicopathologic study of 104 intraductal papillary-mucinous neoplasms
    Nara, Satoshi
    Shimada, Kazuaki
    Kosuge, Tonioo
    Kanai, Yae
    Hiraoka, Nobuyoshi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (02) : 243 - 255